1. Home
  2. CDNA vs NEXA Comparison

CDNA vs NEXA Comparison

Compare CDNA & NEXA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • NEXA
  • Stock Information
  • Founded
  • CDNA 1998
  • NEXA 1956
  • Country
  • CDNA United States
  • NEXA Luxembourg
  • Employees
  • CDNA N/A
  • NEXA N/A
  • Industry
  • CDNA Medical Specialities
  • NEXA Metal Mining
  • Sector
  • CDNA Health Care
  • NEXA Basic Materials
  • Exchange
  • CDNA Nasdaq
  • NEXA Nasdaq
  • Market Cap
  • CDNA 1.1B
  • NEXA 1.2B
  • IPO Year
  • CDNA 2014
  • NEXA 2017
  • Fundamental
  • Price
  • CDNA $23.16
  • NEXA $6.07
  • Analyst Decision
  • CDNA Buy
  • NEXA Sell
  • Analyst Count
  • CDNA 8
  • NEXA 5
  • Target Price
  • CDNA $26.43
  • NEXA $7.40
  • AVG Volume (30 Days)
  • CDNA 823.5K
  • NEXA 38.6K
  • Earning Date
  • CDNA 02-26-2025
  • NEXA 02-19-2025
  • Dividend Yield
  • CDNA N/A
  • NEXA N/A
  • EPS Growth
  • CDNA N/A
  • NEXA N/A
  • EPS
  • CDNA N/A
  • NEXA N/A
  • Revenue
  • CDNA $312,775,000.00
  • NEXA $2,655,440,000.00
  • Revenue This Year
  • CDNA $20.27
  • NEXA $5.82
  • Revenue Next Year
  • CDNA $11.76
  • NEXA $2.31
  • P/E Ratio
  • CDNA N/A
  • NEXA N/A
  • Revenue Growth
  • CDNA 5.26
  • NEXA N/A
  • 52 Week Low
  • CDNA $7.42
  • NEXA $5.10
  • 52 Week High
  • CDNA $34.84
  • NEXA $9.61
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 47.43
  • NEXA 42.35
  • Support Level
  • CDNA $22.50
  • NEXA $5.57
  • Resistance Level
  • CDNA $23.81
  • NEXA $6.39
  • Average True Range (ATR)
  • CDNA 1.21
  • NEXA 0.38
  • MACD
  • CDNA 0.03
  • NEXA 0.03
  • Stochastic Oscillator
  • CDNA 49.08
  • NEXA 49.58

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.

About NEXA Nexa Resources S.A.

Nexa Resources SA is a low-cost integrated zinc producer. It produces copper, silver, and gold as byproducts. The company operates through two segments namely Mining and Smelting. Its Mining segment consists of various operating units includes mineral exploration activities and the production of zinc concentrates, copper concentrates and concentrates. The Smelting segment comprises operating units which include facilities recovering and refining zinc metal out of feed materials such as zinc concentrates or secondary feed materials. It generates maximum revenue from the Smelting segment. Geographically It has a presence in Brazil, Peru, the United States of America, Switzerland, Japan, Argentina, South Korea, Colombia, Vietnam, Malaysia and other countries.

Share on Social Networks: